Global research trends on ALK-TKIs in non-small cell lung cancer: a bibliometric analysis
This study provides a comprehensive bibliometric analysis and summary of the developmental trajectory, current research landscape, and future trends in ALK-TKI therapy for NSCLC over the past decade, with individualized and precision medicine remaining the primary direction for the development of ALK-TKI therapy in NSCLC.
Authors
- Yafeng Liu (ORCID: https://orcid.org/0000-0003-3930-4872)
- Zhibin Han (ORCID: https://orcid.org/0000-0003-4425-147X)
- Qiushi Wang (ORCID: https://orcid.org/0000-0003-0177-3323)
- Pengfei Zhang (ORCID: https://orcid.org/0000-0003-3470-085X)
- Yujia Li (ORCID: https://orcid.org/0000-0002-3216-4822)
Institutions
- Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fphar.2025.1665174
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52